Gary Nachman
Stock Analyst at Canaccord Genuity
(2.18)
# 3,200
Out of 4,639 analysts
489
Total ratings
46.2%
Success rate
0.5%
Average return
Main Sectors:
Stocks Rated by Gary Nachman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACHV Achieve Life Sciences | Reiterated: Buy | $13 | $6.77 | +92.02% | 9 | Aug 12, 2026 | |
| JAZZ Jazz Pharmaceuticals | Reiterated: Buy | $300 | $247.98 | +20.98% | 51 | Aug 11, 2026 | |
| ANIP ANI Pharmaceuticals | Maintained: Hold | $91 → $90 | $74.53 | +20.76% | 6 | Aug 10, 2026 | |
| ADMA ADMA Biologics | Maintained: Buy | $18 | $9.91 | +81.73% | 9 | Aug 6, 2026 | |
| SRRK Scholar Rock Holding | Maintained: Buy | $62 | $52.07 | +19.07% | 14 | Aug 6, 2026 | |
| AMGN Amgen | Maintained: Hold | $366 → $384 | $414.30 | -7.31% | 5 | Aug 5, 2026 | |
| ABBV AbbVie | Reiterated: Buy | $282 → $290 | $250.09 | +15.96% | 45 | Aug 3, 2026 | |
| IONS Ionis Pharmaceuticals | Reiterated: Buy | $95 | $55.42 | +71.42% | 34 | Jul 30, 2026 | |
| ETON Eton Pharmaceuticals | Reiterated: Buy | $60 | $42.05 | +42.69% | 2 | Jul 30, 2026 | |
| PCRX Pacira BioSciences | Maintained: Hold | n/a | $24.38 | - | 48 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16.81 | $9.35 | +79.76% | 7 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 → $20 | $2.79 | +616.85% | 2 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.08 | n/a | 5 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 → $40 | $5.21 | n/a | 2 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $4.41 | n/a | 18 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 → $22 | $16.87 | n/a | 2 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $298 | $221.20 | n/a | 23 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $4 | $77.92 | n/a | 7 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $200 → $100 | $0.0001 | n/a | 8 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 → $4 | $9.60 | n/a | 22 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $4 | $17.10 | n/a | 19 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 → $30 | $8.51 | n/a | 7 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $83 → $78 | $18.65 | n/a | 5 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $14 | $16.28 | n/a | 17 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $11.21 → $14.01 | $8.68 | n/a | 42 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $40 → $32 | $9.76 | n/a | 11 | Feb 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $10 | $36.48 | n/a | 7 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $3 | $42.02 | n/a | 11 | Jan 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 → $35 | $0.0001 | n/a | 10 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $25 | $4.73 | n/a | 6 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $180 | $1.40 | n/a | 3 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $13 → $12 | $17.80 | n/a | 5 | May 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 | $20.42 | n/a | 14 | May 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $3 | $0.0001 | n/a | 5 | Sep 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 | $56.08 | n/a | 1 | Sep 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $138 | $97.23 | n/a | 3 | Apr 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $9.5 → $14 | $4.30 | n/a | 2 | Mar 21, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6.8 | $14.01 | n/a | 2 | Oct 9, 2013 |
Achieve Life Sciences
Aug 12, 2026
Reiterated: Buy
Price Target: $13
Current: $6.77
Upside: +92.02%
Jazz Pharmaceuticals
Aug 11, 2026
Reiterated: Buy
Price Target: $300
Current: $247.98
Upside: +20.98%
ANI Pharmaceuticals
Aug 10, 2026
Maintained: Hold
Price Target: $91 → $90
Current: $74.53
Upside: +20.76%
ADMA Biologics
Aug 6, 2026
Maintained: Buy
Price Target: $18
Current: $9.91
Upside: +81.73%
Scholar Rock Holding
Aug 6, 2026
Maintained: Buy
Price Target: $62
Current: $52.07
Upside: +19.07%
Amgen
Aug 5, 2026
Maintained: Hold
Price Target: $366 → $384
Current: $414.30
Upside: -7.31%
AbbVie
Aug 3, 2026
Reiterated: Buy
Price Target: $282 → $290
Current: $250.09
Upside: +15.96%
Ionis Pharmaceuticals
Jul 30, 2026
Reiterated: Buy
Price Target: $95
Current: $55.42
Upside: +71.42%
Eton Pharmaceuticals
Jul 30, 2026
Reiterated: Buy
Price Target: $60
Current: $42.05
Upside: +42.69%
Pacira BioSciences
Oct 6, 2025
Maintained: Hold
Price Target: n/a
Current: $24.38
Upside: -
Oct 2, 2025
Maintained: Buy
Price Target: $16.81
Current: $9.35
Upside: +79.76%
Aug 13, 2025
Maintained: Buy
Price Target: $3 → $20
Current: $2.79
Upside: +616.85%
Aug 4, 2025
Reiterated: Hold
Price Target: n/a
Current: $2.08
Upside: n/a
Jul 31, 2025
Maintained: Buy
Price Target: $37 → $40
Current: $5.21
Upside: n/a
Jun 17, 2025
Maintained: Buy
Price Target: $7
Current: $4.41
Upside: n/a
Feb 20, 2025
Maintained: Buy
Price Target: $19 → $22
Current: $16.87
Upside: n/a
Jan 15, 2025
Reiterated: Buy
Price Target: $298
Current: $221.20
Upside: n/a
Aug 19, 2024
Maintained: Buy
Price Target: $7 → $4
Current: $77.92
Upside: n/a
Mar 16, 2023
Rated: Buy
Price Target: $200 → $100
Current: $0.0001
Upside: n/a
Mar 8, 2023
Maintained: Buy
Price Target: $5 → $4
Current: $9.60
Upside: n/a
Mar 2, 2023
Rated: Hold
Price Target: $4
Current: $17.10
Upside: n/a
Mar 1, 2023
Maintained: Buy
Price Target: $35 → $30
Current: $8.51
Upside: n/a
Mar 1, 2023
Maintained: Buy
Price Target: $83 → $78
Current: $18.65
Upside: n/a
Feb 27, 2023
Rated: Hold
Price Target: $14
Current: $16.28
Upside: n/a
Feb 24, 2023
Maintained: Hold
Price Target: $11.21 → $14.01
Current: $8.68
Upside: n/a
Feb 22, 2023
Rated: Buy
Price Target: $40 → $32
Current: $9.76
Upside: n/a
Feb 8, 2023
Rated: Hold
Price Target: $10
Current: $36.48
Upside: n/a
Jan 9, 2023
Rated: Buy
Price Target: $3
Current: $42.02
Upside: n/a
Nov 10, 2022
Maintained: Buy
Price Target: $60 → $35
Current: $0.0001
Upside: n/a
Aug 11, 2022
Reiterated: Buy
Price Target: $27 → $25
Current: $4.73
Upside: n/a
Aug 2, 2021
Maintained: Buy
Price Target: $180
Current: $1.40
Upside: n/a
May 14, 2021
Rated: Buy
Price Target: $13 → $12
Current: $17.80
Upside: n/a
May 11, 2020
Maintained: Hold
Price Target: $21
Current: $20.42
Upside: n/a
Sep 5, 2019
Maintained: Buy
Price Target: $9 → $3
Current: $0.0001
Upside: n/a
Sep 14, 2017
Maintained: Buy
Price Target: $80
Current: $56.08
Upside: n/a
Apr 27, 2017
Reiterated: Buy
Price Target: $138
Current: $97.23
Upside: n/a
Mar 21, 2016
Initiated Coverage: Hold
Price Target: $9.5 → $14
Current: $4.30
Upside: n/a
Oct 9, 2013
Maintained: Hold
Price Target: $6.8
Current: $14.01
Upside: n/a